A, K., JP, A., F, N., R, L., PJ, O., N, M., . . . F, G. (2023). Endoscopic endonasal surgery for prolactinomas: Prognostic factors for disease control and management of persistent disease. Neurosurgical review, 46(1), 295. https://doi.org/10.1007/s10143-023-02199-7
Chicago Style (17th ed.) CitationA, Kalyvas, et al. "Endoscopic Endonasal Surgery for Prolactinomas: Prognostic Factors for Disease Control and Management of Persistent Disease." Neurosurgical Review 46, no. 1 (2023): 295. https://doi.org/10.1007/s10143-023-02199-7.
MLA (9th ed.) CitationA, Kalyvas, et al. "Endoscopic Endonasal Surgery for Prolactinomas: Prognostic Factors for Disease Control and Management of Persistent Disease." Neurosurgical Review, vol. 46, no. 1, 2023, p. 295, https://doi.org/10.1007/s10143-023-02199-7.